Biotechnology Stocks
| # | 過去7日 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 4404 | MCRB Seres Therapeutics, Inc. - Common Stock | 2.63 USD | -3.31% | -11.74% | -49.52% | -68.04% | 26.15 M USD | ||
| 4406 | ABVC ABVC BioPharma, Inc. - Common Stock | 0.98 USD | -2.00% | -4.85% | +6.52% | -69.94% | 26.12 M USD | ||
| 4408 | ATYR aTyr Pharma, Inc. - Common Stock | 0.26 USD | -7.14% | -10.34% | -44.68% | -73.20% | 25.50 M USD | ||
| 4410 | EVAX Evaxion A/S - American Depositary Share | 3.05 USD | -2.87% | -5.57% | -7.29% | -8.13% | 25.44 M USD | ||
| 4415 | BYSI BeyondSpring, Inc. - Ordinary Shares | 0.61 USD | -4.69% | -26.51% | 0.00% | -66.67% | 25.08 M USD | ||
| 4432 | ATOS Atossa Therapeutics, Inc. - Common Stock | 2.42 USD | -1.63% | +8.52% | +2.54% | +106.84% | 24.15 M USD | ||
| 4433 | KYNB Kyntra Bio, Inc. - Common Stock | 5.96 USD | -1.32% | -9.70% | -29.22% | -37.33% | 24.13 M USD | ||
| 4474 | COCP Cocrystal Pharma, Inc. - Common Stock | 1.07 USD | 0.00% | -8.55% | -15.08% | -13.71% | 20.61 M USD | ||
| 4503 | JSPR Jasper Therapeutics, Inc. - Class A Common Stock | 0.56 USD | -1.75% | -6.67% | -18.84% | -77.60% | 18.63 M USD | ||
| 4504 | ESLA Estrella Immunopharma, Inc. - Common Stock | 0.42 USD | 0.00% | -8.70% | -32.26% | -66.40% | 18.27 M USD | ||
| 4509 | NEUP Neuphoria Therapeutics Inc. - Common Stock | 3.35 USD | -2.05% | -6.69% | -11.61% | -82.41% | 18.13 M USD | ||
| 4528 | GNTA Genenta Science S.p.A. - American Depositary Shares | 0.71 USD | -6.58% | -13.41% | -23.66% | -78.81% | 16.64 M USD | ||
| 4532 | AKTX Akari Therapeutics Plc - American Depositary Shares | 8.49 USD | -1.62% | -5.77% | -20.13% | +793.68% | 16.53 M USD | ||
| 4538 | ACTU Actuate Therapeutics, Inc. - Common stock | 0.68 USD | -5.56% | -26.88% | -45.60% | -83.33% | 16.33 M USD | ||
| 4541 | BCDA BioCardia, Inc. - Common Stock | 1.06 USD | -2.75% | +1.92% | -2.75% | -8.62% | 16.05 M USD | ||
| 4543 | PTN Palatin Technologies, Inc. Common Stock | 9.01 USD | -5.36% | +3.56% | -26.57% | +24.28% | 16.05 M USD | ||
| 4544 | DYAI Dyadic International, Inc. - Common Stock | 0.44 USD | -4.35% | -4.35% | -13.73% | -61.06% | 16.03 M USD | ||
| 4546 | LPCN Lipocine Inc. - Common Stock | 1.93 USD | -12.27% | -8.53% | -17.87% | -33.45% | 15.91 M USD | ||
| 4548 | MRKR Marker Therapeutics, Inc. - Common Stock | 0.95 USD | -8.65% | -10.38% | -21.49% | -10.38% | 15.84 M USD | ||
| 4554 | ALLR Allarity Therapeutics, Inc. - Common stock | 0.98 USD | 0.00% | -7.55% | -24.03% | -44.32% | 15.59 M USD |
ニュース Biotechnology Stocks
RBCキャピタル、Rhythm Pharmaceuticalsの「アウトパフォーム」を維持、目標株価を159ドルに引き上げ
RBCキャピタル、Exelixisの「セクター・パフォーム」を維持、目標株価を45ドルに引き下げ
ADCセラピューティクス、1株1.42ドルで1,290万株、1ワラント1.32ドルで4,810万株を取得できるワラント付きで8,660万ドルのPIPE資金調達を発表;ローンおよびロイヤルティ契約の修正も確保
NutriBand、AVERSA乱用防止経皮技術の保護強化を目的として米国特許出願を提出
BioLineRx社、GLIX1を取り上げた2件の抄録が11月12日~15日に開催される神経腫瘍学会年次総会で発表されることを発表
Atrium Therapeutics、5,170,384株および最大1,134,930株を購入可能なプレファンドワラントの私募を1ユニット約7.93ドルで実施、総額5,000万ドルを発表
「ロシア、シベリアで2件目の感染報告を否定」 - Bloomberg
Gainers Biotechnology Stocks
GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |